ATTOVIA
Live / Allowed — Publication / registration review complete (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99937656
- Mark type
- Word mark
- Filed
- 13 Jul 2026
- Published for opposition
- 10 Nov 2026
- Attorney of record
- Julia Spoor Gard
Goods and services
- Class 005 — Pharmaceuticals: Biotherapeutics, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, infectious diseases; Biotherapeutics, namely pharmaceutical preparations for the treatment of livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, and infectious diseases
Owner
- Attovia Therapeutics, Inc., San Carlos, CA, US
Prosecution history
- 09 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2026 — USE AMENDMENT ACCEPTED
- 09 Oct 2026 — ASSIGNED TO EXAMINER
- 03 Sept 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 03 Sept 2026 — USE AMENDMENT FILED
- 03 Sept 2026 — TEAS AMENDMENT OF USE RECEIVED
- 13 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 13 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Jul 2026 — NEW APPLICATION ENTERED